FDA Approved: ZELAPAR — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Zelapar (selegiline hydrochloride) filed by Bausch Health US, LLC, indicating changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ZELAPAR (SELEGILINE HYDROCHLORIDE)

Snippet

SUPPL AP for ZELAPAR (SELEGILINE HYDROCHLORIDE)